Methods of treating colon cancer using nanoparticle mtor inhibitor combination therapy
A nanoparticle and inhibitor technology, applied in nanotechnology, nanotechnology, nanomedicine, etc., can solve the problem of death of patients with advanced diseases
Pending Publication Date: 2020-09-18
ABRAXIS BIOSCI LLC
View PDF17 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment approach 1
[0365] Embodiment 1. A method of treating colon cancer in an individual, comprising administering to the individual; a) an effective amount of a nanoparticle-containing composition comprising an mTOR inhibitor and albumin; b) an effective amount of an anti-VEGF antibody ; C) A therapeutically effective FOLFOX regimen.
Embodiment approach 2
[0366] Embodiment 2. The method of embodiment 1, wherein the colon cancer includes abnormal mTOR activation.
Embodiment approach 3
[0367] Embodiment 3. The method of embodiment 2, wherein the abnormal mTOR activation includes abnormal PTEN.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
| Property | Measurement | Unit |
|---|---|---|
| diameter | aaaaa | aaaaa |
| diameter | aaaaa | aaaaa |
| diameter | aaaaa | aaaaa |
Login to View More
Abstract
The present application provides methods of treating a colon cancer (such as advanced and / or metastatic colon cancer) in an individual, comprising administering to the individual: a) an effective amount of a composition comprising nanoparticies comprising an mTOR inhibitor (such as a limus drug, such as sirolimus or a derivative thereof) and an albumin, b) an effective amount of anti-VEGF antibody(such as bevacizumab), and c) a therapeutically effective FOLFOX regimen (such as FOLFOX4 or a modified FOLFOX6).
Description
[0001] Cross references to related applications [0002] This application claims priority to US Provisional Application No. 62 / 607,798 filed on December 19, 2017, the entire disclosure of which is incorporated herein by reference. Technical field [0003] The present invention relates to methods and compositions for the treatment of colon cancer-by including a composition comprising nanoparticles of mTOR inhibitors (such as limus drugs, such as sirolimus or its derivatives) and albumin, combined Anti-VEGF antibody and FOLFOX regimen. Background technique [0004] Colon cancer (colorectal cancer, CRC) has become a major health problem worldwide due to its high prevalence and high mortality. It is the third most common malignancy in developed countries and the second most common cause of cancer-related deaths. Although the progress of CRC treatment has had a significant impact on its management, many patients with advanced disease will eventually die from their cancer. [0005] The m...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/282A61K31/519A61K31/513A61K39/395A61K31/436A61P35/00
CPCA61K39/3955A61K47/42A61P35/00A61K31/436A61K31/519A61K31/513A61K31/555A61K2300/00A61K45/06A61K47/643A61K39/395C07K2317/24C07K2317/76A61K9/5169C07K16/22B82Y5/00A61K9/0019A61K47/6929A61K47/6907A61K47/6925A61P35/02A61K2039/54A61K2039/545
Inventor N·P·德赛
Owner ABRAXIS BIOSCI LLC
PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.
